Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications: supplementary materials

<p dir="ltr"><b>These are peer-reviewed supplementary materials for the article '</b><b>Willingness to pay for a hypothetical </b><b>malaria vaccine in Brazil: a cross-sectional </b><b>study and the implications</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b></p><ul><li><b>Previous knowledge about malaria</b></li><li><b>Information about malaria</b></li><li><b>Conference about context understanding</b></li><li><b>Opinion research</b></li><li><b>Clinical data</b></li><li><b>Exclusive to interviewer</b></li></ul><p dir="ltr"><b>Aim:</b> Malaria is an infection caused by protozoa of genus Plasmodium, considered the one associated with increasingly large outbreaks. <b>Methods:</b> A cross-sectional study was conducted with residents in the northern region of Brazil on the willingness to pay (WTP) for a hypothetical vaccine against malaria (effective protection of 80%). <b>Results: </b>Of 616 people interviewed, most interviewees were female (61%) and were employed (97%). The median individual maximum WTP for a hypothetical malaria vaccine was US$11.90 (BRL 50). <b>Conclusion: </b>The northern region of Brazil is one of the largest markets for a malaria vaccine due to its epidemiological relevance. Consequently, economic studies will be important to assist in the assessment of the potential price and value of new vaccines.</p>